Literature DB >> 6639823

Side effects of amrinone therapy.

T H LeJemtel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6639823      PMCID： PMC481449          DOI： 10.1136/hrt.50.5.499

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


× No keyword cloud information.
  10 in total

1.  Hemodynamic effects of intravenous and oral amrinone in patients with severe heart failure: relationship between intravenous and oral administration.

Authors:  T H LeJemtel; E C Keung; W J Schwartz; C S Maskin; M A Greenberg; R S Davis; R Forman; H S Ribner; E H Sonnenblick
Journal:  Trans Assoc Am Physicians       Date:  1979

2.  Beneficial effects of amrinone-hydralazine combination on resting hemodynamics and exercise capacity in patients with severe congestive heart failure.

Authors:  L A Siegel; E Keung; S J Siskind; R Forman; H Feinberg; J Strom; D Efstathakis; E H Sonnenblick; T H LeJemtel
Journal:  Circulation       Date:  1981-04       Impact factor: 29.690

3.  Haemodynamic effects of intravenous amrinone in patients with impaired left ventricular function.

Authors:  P T Wilmshurst; D S Thompson; B S Jenkins; D J Coltart; M M Webb-Peploe
Journal:  Br Heart J       Date:  1983-01

4.  Sustained beneficial effects of oral amrinone on cardiac and renal function in patients with severe congestive heart failure.

Authors:  T H LeJemtel; E Keung; H S Ribner; R Davis; J Wexler; J D Blaufox; E H Sonnenblick
Journal:  Am J Cardiol       Date:  1980-01       Impact factor: 2.778

5.  The improvement of cardiac performance by amrinone, a new cardiotonic drug, in an experimental failing heart preparation of the dog.

Authors:  K Satoh; M Maruyama; N Taira
Journal:  Jpn Heart J       Date:  1982-11

6.  Amrinone: a new non-glycosidic, non-adrenergic cardiotonic agent effective in the treatment of intractable myocardial failure in man.

Authors:  T H LeJemtel; E Keung; E H Sonnenblick; H S Ribner; M Matsumoto; R Davis; W Schwartz; A A Alousi; D Davolos
Journal:  Circulation       Date:  1979-06       Impact factor: 29.690

7.  Amrinone relaxes potassium-induced contracture of failing right ventricular muscle of cats.

Authors:  M S Gaide; W S Fitterman; J R Wiggins; R J Myerburg; J S Cameron; A L Bassett
Journal:  J Cardiovasc Pharmacol       Date:  1983 Mar-Apr       Impact factor: 3.105

8.  Sustained hemodynamic and clinical effects of a new cardiotonic agent, WIN 47203, in patients with severe congestive heart failure.

Authors:  C S Maskin; L Sinoway; B Chadwick; E H Sonnenblick; T H Le Jemtel
Journal:  Circulation       Date:  1983-05       Impact factor: 29.690

9.  Side effects of amrinone therapy.

Authors:  P T Wilsmhurst; M M Webb-Peploe
Journal:  Br Heart J       Date:  1983-05

10.  Hemodynamic assessment of amrinone. A new inotropic agent.

Authors:  J R Benotti; W Grossman; E Braunwald; D D Davolos; A A Alousi
Journal:  N Engl J Med       Date:  1978-12-21       Impact factor: 91.245
  10 in total
  1 in total

1.  Effects of intracoronary and intravenous amrinone infusions in patients with cardiac failure and patients with near normal cardiac function.

Authors:  P T Wilmshurst; D S Thompson; S M Juul; H C Dittrich; J R Dawson; J M Walker; B S Jenkins; D J Coltart; M M Webb-Peploe
Journal:  Br Heart J       Date:  1985-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.